Medications Leave Lasting Fingerprints on Your Gut Microbiome

Your gut microbiome might be a living record of your medication history, according to a sweeping new study that challenges how researchers think about the bacteria living inside us.

Scientists at the University of Tartu Institute of Genomics analyzed stool samples and prescription records from over 2,500 participants and discovered something striking: most medications they examined left measurable changes in gut bacteria that persisted long after people stopped taking them. We’re not talking about weeks or months. We’re talking years.

Past Medications Matter More Than We Thought

The findings suggest that your prescription history is just as important as your current medications when it comes to understanding your microbiome. “Most microbiome studies only consider current medications, but our results show that past drug use can be just as important as it is a surprisingly strong factor in explaining individual microbiome differences,” said Dr. Oliver Aasmets, the study’s lead author.

This matters because the gut microbiome influences everything from digestion and metabolism to immune function and overall health. If scientists want to understand why one person’s microbiome differs from another’s, they may have been looking at only half the picture.

The study examined several drug classes, and the results were sobering. Antidepressants, beta-blockers, proton pump inhibitors, and benzodiazepines all left distinctive microbial fingerprints that remained detectable long after people stopped taking them. While antibiotics are already known to disrupt gut bacteria, these other medications weren’t supposed to be nearly as disruptive.

One finding stood out as particularly surprising: benzodiazepines, commonly prescribed for anxiety, affected the microbiome in ways comparable to broad-spectrum antibiotics. If you’ve ever taken a benzodiazepine for anxiety or sleep, your gut bacteria likely still carry traces of that medication.

One Size Doesn’t Fit All

Another revelation challenges how researchers currently group medications. Drugs in the same class don’t necessarily affect the microbiome in the same way. Diazepam and alprazolam are both benzodiazepines used for similar conditions, but they disrupted gut microbes with different intensities. This suggests that microbiome studies need to examine individual drugs rather than lumping them together by class.

To strengthen their findings, researchers followed a smaller group of participants over time, collecting stool samples before and after they started or stopped certain medications. The results confirmed that medications themselves were responsible for the changes. When people stopped taking proton pump inhibitors, selective serotonin reuptake inhibitors, or antibiotics, predictable shifts in their gut microbes followed.

Professor Elin Org, the corresponding author, emphasized the broader implications: “This is a comprehensive systematic evaluation of long-term medication effects on the microbiome using real-world medical health records. We hope this encourages researchers and clinicians to factor in medication history when interpreting microbiome data.”

Rewriting the Microbiome Playbook

The practical implications are significant. When scientists investigate links between the microbiome and disease, they need to separate medication-induced changes from disease-related changes. A person’s current microbiome might look different because of antibiotics they took three years ago, not because of their current health status. Without accounting for medication history, researchers could draw misleading conclusions about disease mechanisms or risk factors.

This research adds to a growing body of evidence that your microbiome is essentially a biological time capsule. Your gut bacteria reflect not just what you’re eating today or how you’re living now, but the treatments you’ve received across years. Past prescriptions leave biological traces that linger far longer than most people realize.

The Estonian Biobank’s extensive data made this study possible, providing researchers with both detailed prescription records and microbiome samples from thousands of people. That combination is rare and valuable, which is why this finding carries particular weight.

The takeaway for researchers and clinicians is clear: stop thinking of the microbiome as a snapshot of the present moment. It’s more like a historical record, and understanding it requires looking backward as well as forward.

Source: Estonian Research Council